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Abstract
Autism is a disorder that affects one in 59 children in the United States. The spectrum
disorder affects individuals in early childhood and daily functioning. They may display limited
spontaneous language and play and have difficulty in processing social messages. The literature
review examines the benefits of non-pharmacological and pharmacological interventions in
children with autism spectrum disorder (ASD). The proposed study will be guided by the
phenomenology theory. Based on this theory, semi-structured interviews will focus on
caregiver’s perceptions of their children’s reactions, needs, and care in healthcare settings. The
literature review reveals how certain interventions and treatments have helped this population.
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Introduction
Autism, also known as autism spectrum disorder (ASD), is a developmental disorder
characterized by repetitive and characteristic patterns of behavior and difficulties with social
communication and interaction. “This may include limited spontaneous language and play, an
inability to sustain conversations, and difficulty in processing social messages and cues that
promote socially appropriate behaviors” (Pan, 2010). These limitations produce a challenge to
children with the disability, parents, and school teachers. Horseback riding and swimming are
beneficial in providing a multi-sensory environment that benefits the participant’s behaviors.
Sensory integration interventions focus on understanding that “interferences in neurological
processing and integration of sensory information disrupt the construction of purposeful
behaviors” (Pfeiffer et al. 2011). In one study, data suggested that Ayres’s sensory integration
had a positive effect on transitions, socialization, compliance, and general behavior regulation,
evident during intervention session and in home environments (Watling et al. 2007).
Psychotropic medications are apart of ASD treatment to address aggression, self-injurious
behavior, hyperactivity, and other symptoms. However, there are increasing rates of
polypharmacy of psychotropic medications with little to no evidence on the effect of these
medications on the developing brain.
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Problem Statement
Autism spectrum disorder (ASD), is a developmental disorder characterized by repetitive
and characteristic patterns. The term “spectrum” refers to the wide range of symptoms, skills,
and levels of disability in functioning that can occur in people with ASD. The symptoms are
present from early childhood and affect daily functioning (NINDS, 2019). According to the
Centers for Disease Control and Prevention (CDC) (2019), One in 59 children have been
identified with ASD. Children diagnosed with ASD often show difficulties in performing their
day-to-day performance in self-care, school and play skills. These deficits can lead to social
isolation. Early behavioral interventions have been beneficial in helping children develop social
and language skills such as physical therapy and art therapy. For example, horseback riding has
been effective therapeutic option. Children with ASD improved significantly in areas such as
sensory integration and directed attention as well as improved social motivation and sensory
sensitivity. (Bass et al, 2009). Pharmacological treatment includes psychotropic medication like
antidepressants, stimulants, or neuroleptics. However, the US Food and Drug Administration has
indicated only one medication for use in ASD treatment as risperidone (Rosenberg et al, 2009).

Purpose Statement
The objective of the paper is to determine if there are benefits of nonpharmacological and
pharmacological treatments provided together for autistic children, and if so, what are they.

Literature Review
The eight articles were found and selected with the keywords: autism, autism children,
pharm, pharmacological, nonpharm, nonpharmacological, treatment, medication, therapy,
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children, intervention, occupational therapy, and physical therapy. Articles were found in
databases: Google Scholar, Elsevier, and Iceberg. The criteria for choosing the articles to review
were: publishing year, treatment, non-treatment, interventions, children, adult, and autism. The
research and findings were conducted and founded in between 1997-2016 with the primary
diagnosis of the participants having Autism Spectrum Disorder. Refer to Appendix A for
literature review table.
The eight articles I have chosen have been categorized into physical activity, sensory
integration, and pharmacology. Physical activity is an important part of a healthy lifestyle.
Studies have reported positive physical and behavior effects for children with ASDs. Autism can
present with symptoms that are categorized into somatosensory disturbance, atypical
developmental patterns, mood disturbances, and problems with attention and safety. Another
common ASD treatment regimen incorporates pharmacological interventions.

Physical Activity
The article, Effects of water exercise swimming program on aquatic skills and social
behaviors in children with autism spectrum disorders by Pan (2010) explores the benefits of a 10
week water exercise swimming program (WESP) on aquatic skills and social behaviors of
participants with ASD. Physical activity in the aquatic environment enables initiation of
independent movements that are hard to accomplish on land due to gravity. The remedial
utilization of water exercises or swimming in children with ASDs is believed to foster language
development and self-concept.
The individual’s aquatic skills and social behavior data were collected three times, the
first time at entry to create a baseline, a second time after ten weeks of WESP or regular activity,
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and a third time after another ten weeks (Pan, 2010). With regards to swimming experience, few
of the subjects have gone to swimming lessons prior to the study however, all participants had
restricted breathing, floating, and stroke abilities dependent on parent reports and first evaluation
at study entry. Participants were split into two groups, A and B. Group A received WESP for the
first ten weeks, second assessment after the WESP, then regular treatment or activity and third
assessment. The arrangement was reversed for subjects in group B. The study lasted 21 weeks,
ten weeks WESP, ten weeks control, and one week transition.
“During each WESP session, two children with ASDs were paired with the same
instructor each session. Each session was divided into four categories: (A) social and floor
warm-up activities, (B) one-to-two small group instruction, (C) whole group games/activities,
and (D) cool-down activities” (Pan, 2010). The student to instructor ratio allows for individual
instruction, allowing the swim instructor to follow the student’s progression and to adapt to other
factors and challenges. WESP also provides games and group activities, allowing the student to
become apart of the class while gaining independence.
“Results indicate that WESP improved the aquatic skills in four out of five stages as
measured with percentage scores, and decreased the total antisocial behavior problems in
children with ASDs” (Pan, 2010). The results yielded from the study were similar to other
studies conducted on physical activity -- “children with ASDs showed improvement in scores on
water orientation skills, breathing skills, floating skills, stroke skills, and entry and exit skills
over an extended period of program” (Pan, 2010). The participants were assessed in balance,
speed, agility, power, upper and lower extremity muscle strength, flexibility, and cardiorespiratory endurance, showing an increase in the said increments.
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To maximize potential positive impacts, WESP was carefully designed according to
variables such as: child’s age, disability, experiences on the water, play skills, and interests and
needs of the family (Pan, 2010). WESP resulted in decreased antisocial behavior problems but
not increase social competence behaviors. However, many children with autism benefit from
watching the positive social interactions of others.
Similarly, another article The Effect of Therapeutic Horseback Riding on Social
Functioning in Children with Autism Bass et al., (2009) considers the effects of a 12 week
therapeutic horseback riding intervention on social functioning in children with autism. Research
has suggested animal assisted therapy can influence physiological factors. “Therapeutic
horseback riding, a subtype of animal assisted activities, has also been [utilized] to treat
populations with both physical and mental disabilities” (Bass et al., 2009). Therapeutic
horseback riding is defined as “using horseback riding treatment to improve posture, balance,
and mobility while developing a therapeutic bond between the patient and the horse” (Bass et al.,
2009). Therapeutic horseback riding stimulates multiple disciplines of functioning and may be
appropriate for children with neurological disorder who often present a blend of motor,
psychological, and social incapacities.
Bass et al. (2009) used Social Responsiveness Scale (SRS) and Sensory Profile (SP) to
assess social functioning pre- and post-intervention. The Social Responsiveness Scale is a 65item questionnaire that measures the severity of ASD in natural social settings. The five
treatment subscales are: social awareness, social cognition, social communication, social
motivation, and autistic mannerisms. The Sensory Profile is a 125-item questionnaire that
addresses the overall social function and the degree to which children exhibit problems in
sensory processing, modulation, and behavioral and emotional responses (Bass et al., 2009).
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Each child in the treatment group received a therapeutic riding session for an hour a
week, over the span of 12 weeks. The mounting and dismounting of the horse was aimed at
stimulating verbal communication, proprioception, and vestibular processing. Arm circles, trunk
twists, and toe touches were designed to condition the individual for the physical demands of
horseback riding.
Riding the horse was “designed to stimulate sensory seeking, as well as gross and fine
motor domains” (Bass et al., 2009). Instructors led the games that focused on social and
communication skills. Examples of the games included “Simon says,” red light/green light, catch
and throw, and letter games. The horsemanship segment allowed children to learn to properly
groom and care for their horse by learning to identify grooming tools and bathing tools.
Bass et al (2009) verbally and physically reinforced participants with high-fives and hugs
upon completion of each exercise. Instructors and volunteers made efforts to maintain eye
contact with all participants through the therapy session. “Results revealed that the experimental
group significantly increased between pre- and post-testing, [whereas] the control group only
marginally increased” (Bass et al., 2009). The study suggest that therapeutic horseback riding
may be an efficacious remedial choice for children with autism spectrum disorders. Children in
the experimental group improved in critical areas such as sensory integration and directed
attention. They also demonstrated improved social motivation, sensory sensitivity, and a
decrease in inattention and distractibility (Bass et al., 2009).
Individuals diagnosed with ASDs is widely increasing, therefore it is important to
identify recreational activity that may benefit this population. Swimming can enhance a child’s
competence and foster an appreciation of proficient movement. “The kinesthetic stimulation
provided by horseback riding is unique compared to generic forms of physical therapy” (Bass et
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al., 2009). Overall, both swimming and horseback riding yielded results in improved and desired
behavior in independence and directed attention. These studies are the first of its kind and future
studies should increase the length and number of sessions to test and further develop more
intense forms of physical activity interventions.

Sensory Integration
Pfeiffer et al. (2011) conducted a study called Effectiveness of Sensory Integration
Interventions in Children with Autism Spectrum Disorders: A Pilot Study. The purpose of this
study was to establish a randomized control trial research, identify appropriate outcome
measures, and address the effectiveness of sensory integration (SI) intervention in children with
ASD (Pfeiffer et al., 2011). Sensory processing disorder (SPD) is quite common among children
with ASD; reports in the literature range from 42%-88% (Pfeiffer et al., 2011). Sensory
integration disorders often lead people to have extreme responses to what others consider mild
stimuli, or to completely shut down and withdraw from society. With sensory processing
abnormalities, typical behavior displayed includes stereotypic motor movements, aimless
running, aggression, and self-injurious behaviors. These behaviors can interfere with a child’s
ability to engage or learn in therapeutic activities.
Sensory integration (SI) theory concentrate on the neurological processing of sensory
data. SI theory is based on the comprehension that impedances in neurological processing and
integration of tactile data disrupts the development of purposeful behaviors. The goals of
treatment were to improve attention and cognitive function while decreasing disruptive and
repetitive behaviors. Participants were split into two, one group received SI interventions and the
other group received fine motor (FM) interventions. “Interventions were provided in the context
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of the summer therapeutics activities program. Activities are to help the nervous system
modulate, organize, and integrate information from the environment, resulting in future adaptive
responses” (Pfeiffer et al., 2011).
SI-based treatment involves meaningful therapeutic activities distinguished by
enhancement of sensation, touch, hearing, proprioceptive, active participation, and adaptive
interaction. The interventions are individualized to the needs of each child but include the 10 key
therapeutic strategies: arranging the room to entice engagement, ensuring physical safety,
presenting sensory opportunities, attaining and maintaining optimal arousal levels, tailoring
activities to present the just-right challenge, ensuring that activities are successful, guiding the
self-regulation of behavior, creating a playful context, collaborating in activity, and fostering
therapeutic alliances (Pfeiffer et al., 2011).
The fine motor treatment group participated in individual sessions with an occupational
therapy graduate student. The FM interventions focused three activity areas of constructional,
drawing and writing, and FM crafts. According to Pfeiffer et al, (2011) studies, FM interventions
were to meet the fidelity criteria of: appropriate supports provided for the child to successfully
accomplish the tasks while challenging their fine motor and visual-motor skills, interventions
based on therapeutic needs of the child in areas of visual and FM skills, interventions based on
the child’s interests to maintain attention and focus on the task, seating and positioning of the
child adapted to address their specific size and motor support needs, as well as activities that do
not provide full-body proprioceptive, vestibular, or tactile sensory input. During the pretest phase
of the study, it was discovered that the participants lacked occupational therapy services within
the program due to limited funding.
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Measurement tools were used to further assess in-depth criteria. Sensory processing
measure (SPM) is a 4-point Likert-type scale that surveys processing issues, praxis, and social
participation, providing a complete picture of the child’s sensory processing difficulties at
school, home, and in the community. The SPM was used to distinguish the two groups. Social
responsiveness scale (SRS) is a 65-item rating scale that measures a child’s social impairments
such as social awareness, social information processing, capacity for social communication,
social anxiety and avoidance, and autistic preoccupations and traits. Results were used to
differentiate children with PPD and other diagnostic conditions, showcasing strong discriminant
variability (Pfeiffer et al., 2011).
The Quick neurological screening test, 2nd edition (QNST-II), assesses 15 areas of
neurological integration that was used to predict scores and results in areas including praxis,
hand agility, visual tracking, and motor skills. The goal attainment scaling (GAS) is an objective
setting procedure used to determine intervention outcomes explicitly relevant to individuals and
their families. The purpose of the tool was to develop goals with the parents to ensure the goals
were relevant and appropriate for the child. Vineland adaptive behavior scales, 2nd edition
(VABS-2) is “an individually administered measure of adaptive behaviors that assesses the
domains of communication, daily living skills, socialization, and motor skills” (Pfeiffer et al.,
2011). This measurement tool was used to control validity.
In the study, results demonstrated significant changes in the autistic mannerisms. “Post
Intervention differences in social responsiveness between the SI and FM groups [showed that]
children in the SI group had significantly fewer autistic mannerisms after interventions” (Pfeiffer
et al., 2011). Pfeiffer mentions a study where autitic people who use self-stimulatory behaviors
allowed them to process sensory information without sensory overload. But, the evident
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reduction of autistic mannerisms and self-regulatory behaviors may indicate a better ability to
process sensory stimuli without the need for regulatory strategies (Pfeiffer et al., 2011). A
significant difference was noted in the QNST-2 testing. Participants who received the SI
interventions were more competent in completing the standardized test post-test as opposed to
their counterpart.
In a study analyzed in 2007, a group of researchers examined the effects of Ayres’s
sensory integration intervention on the behavior and task engagement of young children with
ASD in the research article Immediate Effect of Ayres’s Sensory Integration-Based Occupational
Therapy Intervention on Children with Autism Spectrum Disorders. Watling and Dietz created
individualized material for each child’s baseline. Some materials used in the treatment phases
were swings, rope ladder, small trampoline, scooter board and ramp, balance beams, and toys
that challenge bilateral coordination and manipulation (Watling, 2007). Ten activities met the
criteria of activity demands matching the cognitive and fine motor skills of the child and the
activity having the tendency to evoke attention and engagement. Examples of the activities were
puzzles, stickers, beads and strings, and blocks.
The study sessions had three phases, familiarization, baseline, and treatment. The
familiarization phase consisted of the child and occupational therapist freely playing with the
specified toys. Baseline sessions were like free-play scenarios, similar to a preschool
environment. “The therapist continually observed the child’s responses to activities and made
modifications as needed to offer an appropriate level of challenge that encouraged the
development of new skills” (Watling, 2007). All study sessions were videotaped because review
footage is the most common method of data analysis for single-subject research. According to

BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS14
IN AUTISTIC CHILDREN
Watling (2007), an additional benefit to visual inspection is that it increases confidence that
observed performance changes are due to intervention.
According to Watling’s data, it can be presumed that Ayres’s sensory integration had a
positive effect on transitions, socialization, compliance, and general behavior regulation; evident
during intervention session and in home environments. “The present study found that the rates of
undesired behavior immediately after Ayres’s sensory integration were similar to those after
playing conditions” (Watling, 2007). The children showed improvements in transitions between
activities. Findings for engagement were not supportive of Ayres’s sensory integration but one
participant demonstrated “his highest rates of engagements on the 4 of the last 5 days of study,
suggesting that his task engagement improved over time” (Watling, 2007). Studies on Ayres’s
sensory integration for children with ASD is limited, therefore it is ideal to have well-controlled
studies and reliable outcome measures to understand the effectiveness of SI. The study was to
record subjective data that may guide future research in the area. The low population sample,
short trials, and potential for bias are limitations in both research articles.

Pharmacology
Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled
in a National Registry, 2007-2008 by Rosenberg et al. (2009), investigates the trends of
prescription medication for children with autism. The US Food and Drug Administration only
indicated Risperidone for treatment of autism but many other medications are also prescribed.
“Treatment of ASD often includes psychotropic medications to address aggression, self-injurious
behavior, hyperactivity, anxiety, sleep problems, and other symptoms common in children with
these disorders” (Rosenberg et al., 2009). As stated in previous studies, it is estimated that 30-
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60% of children with ASD use at least one psychotropic medication, predominantly
antidepressants, stimulants, or neuroleptics (Rosenberg et al., 2009).
Between April 2007 to October 2018, a total of 5,181 children were sampled and findings
concluded that the sample was predominantly male (83%), age 6-11 years old (49%), and often
reported psychiatric comorbidities (39% with ≥ 1 comorbidity) (Rosenberg et al., 2009).
Older children were more likely to be prescribed medication than younger children. Those who
reported no insurance coverage were less likely to be on more than two medications compared to
individuals who had private insurance, Medicaid, or a combination of both. According to the
results, psychotropic medication use is associated with geographic characteristics. “Increased
medication use in poorer areas may reflect that these children have less access to behavioral and
education supports and thus use more pharmaceutical interventions” (Rosenberg et al., 2009).
This greatly reflects the access to specialty health care and inconsistent guidelines for
pharmaceutical management of ASD.
Similarly, Psychotropic Medication Use and Polypharmacy in Children With Autism
Spectrum Disorders by Spencer et al., (2013) examines the rates and predictors of psychotropic
use and multiclass polypharmacy among commercially insured children with ASD. Research
shows increasing rates of psychotropic uses and polypharmacy in children overall and in children
with ASD. General apprehension about such medications are the absence of proof reporting the
safe or adequacy of psychotropic treatment during adolescence. Developing brains and bodies
may be vulnerable to organic impacts.
Data was gathered through a large database associated with a large US commercial health
plan that discovered “a total of 33, 565 children with ASD who had at least 6 months of months
of continuous medical, pharmacy, and behavioral health care coverage between January 2001
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and December 2009 were identified” (Spencer et al., 2013). Household income, ethnicity, age,
geographic location, co-occuring conditions, and having had a specialist visit were seen as
altogether significantly related to psychotropic use and polypharmacy. Spencer et al. (2013)
identified that common class combinations were antidepressants and ADD medications (38% of
subjects), antipsychotic and ADD medications (28%), antipsychotics and antidepressants (20%),
and antipsychotic, antidepressant, and ADD medications (18%). A large proportion of children
who have autism have comorbidities like epilepsy and seizures, ADD, anxiety, depression, and
bipolar disorder. This population are psychotropic users and more than half are users of
polypharmacy. Results showed that common combinations of classes were antidepressants and
ADD medications, antipsychotics and ADD medications, antipsychotics and antidepressants, and
all 3-- antipsychotics, antidepressants, and ADD medications (Spencer et al., 2013). Such
statistics are beneficial in understanding treatments for children and potentially older children
with ASD.
In Risperidone and Explosive Aggressive Autism by Horrigan and Barnhill (1997) the
objective was to further understand Risperidone and its effect in a broader age range of severe
explosive autistic individuals. “Risperidone is a benzisoxazole with potent antipsychotic
properties” (Horrigan, 1997). The drug reduced extrapyramidal side effects with a quick onset of
action. 11 male patients age 6 to 34 years old participating in the study. Initial evaluation
concluded of a physical examination, neurological examination, and blood work as needed.
Ripseridone was started at 0.5 mg orally, once daily at bedtime as disturned sleep hygiene was
exacerbating, and aggravating factor found in eight of the patients (Horrigan, 1997). Doses were
titrated higher, gauged by adult caretaker reports in increments of 0.25-0.5 mg every 5 to 7 days.
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Subjects had follow-up visits to further monitor side effects such as changes in appetite,
somatic complaints, mood changes, quality of social interactions, compulsive or stereotypical
behaviors, and changes in the pattern of self-directed and externally directed aggression. Results
showed major clinical improvement in each patient as early as the first 24 hours after risperidone
was administered. “Aggression (hitting, kicking, biting), self-injury (head banging, self-biting),
explosivity (sudden, intense tantrums occurring with little or no provocation), overactivity
(persistently elevated levels of motor activity), and poor sleep hygiene (difficulty falling asleep,
difficulty staying asleep) diminished most significantly” (Horrigan, 1997). None of the patients
reported dizziness or other side effect that may propose orthostatic hypotension, changes in pulse
or blood pressure. The precise dose of risperidone was achieved for each subject after a 4 week
period. It was noted that temper outbursts were the strongest and most consistent drop in all
participants. Overall, the study was indicative that risperidone therapy was most effective in the
subjects of explosive, autistic males. However, more studies are to be done to study more serious
side effects such as neuroleptic malignant syndrome and tardive dyskinesia.
Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum
disorders: a randomized controlled trial by Anagostou, Soorya, Chaplin, Bartz, Halpern,
Wassermanm, Wang, Pepa, Tanel, Kushki, Hollander (2016), the objective is to study the safety
and therapeutic effects of intranasal oxytocin versus placebo in adults with ASD. Oxytocin has a
unique role in influence social behaviors and has potential for generating animal models with
behavior deficits relevant to ASD (Anagostou, 2016). Evidence has shown that individuals with
ASD have a reduction of oxytocin mRNA in the temporal cortex which is associated with
hypermethylation. “Oxytocin has been shown to play a role in social recognition, memory, and
attachment, as well as in stereotyped behaviors [like] exaggerated grooming” (Anagostou, 2016).
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The current study is following another study where intranasal oxytocin (IN-ONT) promoted trust
and prosocial behavior in humans. “Participants receiving oxytocin showed reduced amygdala
activation to social stimuli more than nonsocial kinds of stimuli, further suggesting that oxytocin
is mediating human social behavior” (Anagostou, 2016).
The randomized, double-blind, placebo-controlled, parallel design trial study was quite
selective wherein participants were to be 18 to 60 years old and on stable pharmacological or non
pharmacological treatments for at least 3 months. Exclusion criteria included bipolar disorder,
psychosis, post-traumatic stress disorder, schizophrenia, respirtal, renal, hepatic or
gastrointestinal disease. Sexually active women were to be on two barriers of contraceptives and
no hormonal birth control. Oxytocin and placebo were administered via nasal spray twice-daily
for six weeks. Anagostou et al., assessed the participants every two weeks for improvement
ratings, vital signs, and measures of repetitive behaviors. Subjects kept a medication diary to
document when they took the medication. “The diary was reviewed at every visit and the study
clinician and participant problem-solved together in the case of missed doses to improve
compliance” (Anagostou, 2016).
In conclusion to the study, oxytocin was well tolerated with no serious side effects
reported. In the oxytocin group, two have reported increased irritability of mild to moderate
severity and two others have reported allergy symptoms. In the placebo group, there were reports
of mild cough, depressed mood, and fatigue (Anagostou, 2016). Although there were no
significant differences found between blood work in oxytocin and placebo, it is the first study to
trial daily administration of IN-OXT in autistic individuals. Risperidone is a common
pharmacological intervention yet side effects may be severe. Other treatments such as oxytocin is
a newer study that may employ as an alternative.
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Physical activity is beneficial to everyone. Swimming exercises the whole body without
putting excessive stress or tension on specific body parts. Participants responded well to the
intervention and demonstrated independence and skills. Therapeutic horseback riding allowed
the subjects to better enhance their sensory integration and directed attention. Sensory processing
disorder is a common symptoms of autism where individuals may display extreme responses and
behaviors. Ayres’s sensory integration interventions aims were to improve attention and
cognitive function. Data has shown a positive effect on socialization, compliance and regulation
of general behavior. Pharmacological treatment is common in many children and often treats
symptoms non pharmacological therapy cannot help. Risperidone is a commonly prescribed
medication that has benefited those with explosive autism and other unwanted symptoms. Trial
run of oxytocin has benefitted some individuals as well.
Autism is a disease that has affected many. The wide broad spectrum of symptoms
arrayment makes treatment difficult and highly individualized in both pharmacologic and
nonpharmacologic interventions. Some gaps identified in the current research are population
sizes, short duration of testing, and limited research on pharmacological trends. Population sizes
ranged from 12 to 34 participants lasting for a few months. More research is to be done on a
grand scale. Another unexplored topic is the adaptability to hospitals. Hospitals provide an
unpredictable timeline which may create frustration among people with ASD. There are often
symptoms that non-pharmacological interventions cannot prevent or fix. Pharmacological
interventions and medication are a necessary aid in other symptomatic management.
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Research Proposal
What are the caregiver’s perceptions of their children’s reactions, needs, and care in
healthcare settings? Studies have shown the benefits of physical activity, sensory integration, and
pharmacology in the treatment of children with ASD. Physical activity yielded positive attitude
changes as well as learned skills in swimming and horseback riding. Sensory integration
interventions demonstrated fewer autistic mannerisms as well as decreased undesired behaviors
such as: stereotypical motor movements, aimless running, aggression, and self-injurious
behaviors. Due to the wide array of symptoms, each child has an individualized care and set of
interventions. It has been noted that medication is given to treat symptoms that are
unmanageable by non-pharmaceutical interventions. “Treatment of ASD often includes
psychotropic medications to address aggression, self-injurious behavior, hyperactivity, anxiety,
sleep problems, and other symptoms common in children with these disorders” (Rosenberg et al.,
2009). These interventions benefit children in the outside world. However, there is limited
research in understanding children with ASD in the healthcare setting.

Theoretical Framework
The theoretical framework used to guide this research was phenomenology. This theory
describes the lived experience with the aim of finding the meaning in experiences and making
sense of it (Schmidt & Brown, 2012). This study will provide insight from caregivers and
children with ASD of their lived experiences in hospitals and healthcare settings. Caregivers’
perceptions were studied to distinguish and depict themes and trends and to discover approaches
to help children have an easy transition in such experiences. The phenomenology theory design
will obtain data through semi-structured interviews with caregivers. Through the interviews, data
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will be collected and analyzed, resulting in theme descriptions. The primary research aim is to
further understand caregiver perceptions of their children with ASD and their visits with
healthcare providers.

Ethical Considerations
The five ethical principles I will abide to are: minimizing risk of harm, obtaining
informed consent, protecting anonymity and confidentiality, avoiding deceptive practices, and
providing the right to withdraw (Laerd Dissertation, 2012). I will obtain consent for the audio
recording of the interviews. I will assign a study ID to each participant and no private
information will be revealed. Participants confidentiality will be maintained. Recruitment, data
collection, and ethical considerations will begin after the study was approved by the Internal
Review Board of the Dominican University of California.
Potential ethical issues include: informed consent, beneficence, respect for anonymity
and confidentiality. Informed consent is to ensure the patient’s right to autonomy is protected. “It
is essential to describe any physical harm or discomfort, any invasion of privacy and any threat
to dignity as well as how the subjects will be compensated in that case” (Burns, 2015). In
interviews, participants share intimate details that may open old wounds. If risks outweigh the
benefits, the study will be revised (Burns, 2015). Anonymity protects the subject’s identity and
cannot be linked with the personal responses given while confidentiality allows individuals to
give and withhold information as they choose.
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Research Method
The qualitative study will use a design based in phenomenology to describe the lived
experiences of caregivers of children with ASD. The standardized open-ended interview is a
structured study design where participants are asked identical questions with open-ended
responses. The open-ended questions allow participants to contribute detailed information. The
sample population will represent caregivers of children with autism spectrum disorder.
The projected sample size of this study will include six participants, including family
members and caregivers. Participants will be recruited through social media, schools, or pediatric
hospitals, and autism associated organizations where participants are eligible to request for more
information. Once informed consent is obtained, demographic information will be collected. The
semi-structured interviews will be voice recorded.
Research focusing on the experiences of individuals with autism and their families is on
the rise. This is due to the growing attention on individuals with ASD and recognizing the impact
of ASD on families. In Qualitative research with families living with autism spectrum disorder:
Recommendations for conducting semistructured interviews by Cridland et al. (2015), provides
insight and experiences of a research team conducting a range of qualitative methods,
particularly semi structured interviews. “Semi-structured interviews involve in-depth
conversations between the researcher and interviewee, which have an overall purpose prompted
by the research aims, but are strongly guided by the interviewee’s perceptions, opinions, and
experiences” (Cridland et al., 2015). Analysis and interpretation of qualitative research can be
influenced by other variables such as preparation, data collection, transcribing, and reading of
transcripts. I will use content analysis to search for repeated phrases or words and from the
words, themes will be developed.
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Conclusion
Autism is a disorder that affects individuals differently. The spectrum of symptoms vary
with very individualized care and treatment. The literature review suggests that there are many
interventions involved in treating ASD. Non-pharmacological and pharmacological interventions
intermingle and treat other symptoms that other interventions cannot. A common and successful
intercession was physical activity. Although exercises varied, sensory integration and directed
attention improved. To combat those with sensory processing disorders, sensory integration
interventions were implemented and displayed enhancement in attention and cognitive function.
Pharmacological studies identified that a majority of children with ASD use at least one
psychotropic medication to combat symptoms of aggression, self-injury, explosivity,
overactivity, and poor sleep hygiene. However,

Implications for Nursing Practice
In order to properly care for children with ASD, the nurse and health care team must
understand non-pharmaceutical and pharmaceutical interventions that have been implemented
into care. This literature review suggests that there are many ways to treat temperaments. As
nurses, the people they encounter at the hospital may range from individuals with disabilities to
disorders and diseases. Children and adults alike have social and communication difficulties that
may make it more difficult to communicate and have their healthcare needs met.
The focus is to help children in the acute setting. Caring for individuals with ASD has
come a long way. Identifying people with ASD has played a role in improving their overall
quality of life. Staff who conduct clinical assessment should look for indicators of ASD through
the patient’s social interactions, communication, and behaviors as well as responding to the
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concerns raised by parents. Nurses can play a role in reducing exacerbations of unwanted
behaviors, education to family members, caregivers, and peers. This can be especially important
for children with autism who are admitted to the hospital for acute exacerbations.
The literature review displayed non-pharmacological and pharmacological interventions
currently available for children with ASD. The literature suggests that each intervention is
effective but durations of the study can be elongated as well as an increase in sample size and
follow-ups. It is still unknown as to what long-term effects these interventions, both nonpharmacological and pharmacological may have on the children and their growing brain. ASD
continues to present obstacles in the daily lives of children and their families. Research is needed
to further understand better coping mechanisms and styles that may be implemented on a global
scale.
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Author (Year)
Title
Citation

Purpose

Design and Sample

Methods

Limitations and
Strengths

Intranasal
oxytocin versus
placebo in the
treatment of
adults with autism
spectrum
disorders: a
randomized
controlled trial

To study the
supports the
therapeutic
potential and safety
of daily
administration of
IN-OXT for social
cognition/function
deficits and
possibly repetitive
behaviors in adults
with ASD

- Pilot, randomized,
double-blind,
placebo-controlled,
parallel design trial

- 19 adults with
ASD, 16 males

Limitations
- Duration of the
study was only 6
weeks and as such
we may have
underestimated the
potential impact of
oxytocin on core
symptom domains

Anagnostou, E.,
Soorya, L.,
Chaplin, W.,
Bartz, J., Halpern,
D., Wasserman,
S., … Hollander,
E. (2012).
Intranasal
oxytocin versus
placebo in the
treatment of
adults with autism
spectrum
disorders: a
randomized
controlled trial.
Molecular

- Recruited through
advertisements in
local media
- Subjects were
randomized to 24
IU intranasal
oxytocin or placebo
in the morning and
afternoon for 6
weeks

- The three female
participants were all
premenopausal and
on no hormonal
contraception, but we
did not collect data
on the time of
menstrual cycle that
may potentially
interact with
oxytocin
- Study did not
follow-up the
participants once the
medication had been
stopped

29

Findings

- 6-week use of INOXT versus placebo
resulted in
improvements in
aspects of social
cognition, repetitive
behaviors and
emotional wellbeing
in some, although not
all
- Study did not report
any serious adverse
effects and IN-OXT
was well tolerated
- Participants
administered with
oxytocin showed
improved positive
evaluations of
appearance and
speech performance,
suggesting that
following exposure
therapy the
administration of
oxytocin improved
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Author (Year)
Title
Citation

Purpose

Design and Sample

Methods

Autism, 3(1), 16–
24.
https://doi.org/10.
1186/2040-23923-16

Limitations and
Strengths

30

Findings

Strengths
the mental
- Pilot study suggests representations of
that there is
self
therapeutic potential
to daily
administration of
intranasal oxytocin in
adults with ASD and
that larger and longer
studies are warranted
- First study to
employ an acute
treatment trial of
daily administration
of IN-OXT in ASD

The Effects of
Therapeutic
Horseback Riding
on Social
Functioning in
Children with
Autism
Bass MM,
Duchowny CA, &
Llabre MM.

To study the
effects of
therapeutic
horseback riding
on social
functioning in
children with
autism

- Quasiexperimental
- Hypothesis testing
- Participants
randomly assigned
to experimental or
control group

- Social Responsive
Scale (SRS) and
Sensory Profile
(SP) were used to
assess social
functioning at pre
and post
intervention

- 34 children with
ASD had 12 weeks
of therapeutic

- Received a
therapeutic riding
session 1 hr/week

Limitations
- No information
about medication
regimens
- Limited to case
reports and
descriptive studies

- Results suggest that
therapeutic
horseback riding may
be an efficacious
therapeutic option for
children with ASD

- Compared to
control group, ASD
- Unknown if parents children in the
of participants in
experimental group
either
improved in critical
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Author (Year)
Title
Citation

Purpose

(2009). The effect
of therapeutic
horseback riding
on social
functioning in
children with
autism. Journal of
Autism &
Developmental
Disorders, 39(9),
1261–1267.
https://doi.org/10.
1007/s10803-0090734-3

Risperidone and
Explosive
Aggressive
Autism
Horrigan JP, &

To explore the
application of
risperidone in a
broader age range
of autistic
individuals with
severe explosive

Design and Sample

Methods

horseback riding
and one post testing
session

over span of 12
weeks

- Quantitative and
Qualitative

- Autism had to be
primary condition

- Complete physical
examination,
including a
neurological

- Risperidone
administered in an
open-label,
nonblind fashion to

Limitations and
Strengths

31

Findings

experimental/control areas such as sensory
group were taking
integration and
part in any therapy or directed attention
- 2 x 2 mixed design self-help classes
repeated measure
- Participants
analysis of variance - Intervention lasted demonstrated a
(ANOVA)
only 12 weeks
sustained level of
examined whether
directed attention and
treatment resulted
- 6 participants
focus, usually not
in an increase in
dropped out of
seen in children with
social functioning
experimental group, ASD
for experimental
3 from control
group compared to
control
Strengths
- Innovative
- Other studies have
examined the effects
of animal assisted
therapy
Limitations
- Possible that
risperidone may have
lowered the seizure
threshold in a
vulnerable
individual, similar to

- Substantial clinical
improvement was
noted almost
immediately in each
patient, with
aggression, selfinjury, explosivity,
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Author (Year)
Title
Citation

Purpose

Barnhill LJ.
(1997).
Risperidone and
explosive
aggressive
autism. Journal of
Autism &
Developmental
Disorders, 27(3),
313–323.
Retrieved from
https://search.ebs
cohost.com/login.
aspx?direct=true
&db=ccm&AN=1
05822413&site=e
ds-live

aggressive, with
the supposition
being that
risperidone might
prove to be a more
effective and better
tolerated agent
than the other
classes of
medications

Design and Sample

Methods

examination and lab 11 males
work
- Patient age range
- Side effects
from 6-34 years old
monitored via
standardized
questions
addressing such
issues as changes in
appetite or sleep
hygiene, somatic
complaints

Limitations and
Strengths
the potential of other
neuroleptics
- A larger scale,
placebo-controlled
study involving both
sexes would be
worthwhile to
confirm these initial
findings

32

Findings

and poor sleep
hygiene most
improved

- Marked clinical
improvement was
noted in each patient,
with the most
significant gains
noted within the first
24 hours of
- Little written on the risperidone therapy
use of risperidone in in all but one patient
the autistic
(Patient A)
population
- Aggression (hitting,
Strengths
kicking, biting), self
- Further develop and injury (head-banging,
learn about
self-biting),
risperidone effects on explosivity (sudden,
autism
intense tantrums
occurring with little
- Treatment was
or no provocation),
individualized for
overactivity
each candidate, doses (persistently elevated
were titrated
levels of motor
upwards, gauged by activity), and poor
adult caretaker report sleep hygiene
(difficulty falling
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Author (Year)
Title
Citation

Purpose

Design and Sample

Methods

Limitations and
Strengths

33

Findings

asleep, difficulty
staying asleep)
diminished most
significantly
- Further advances in
the dose were ceased
after the onset of
unwanted side effects
or after all parties
had agreed that a
satisfactory degree of
improvement had
occurred
Effects of water
exercise
swimming
program on
aquatic skills and
social behaviors
in children with
autism spectrum
disorders
Pan, C.-Y.
(2010). Effects of
Water Exercise

To determine the
effectiveness of a
10 week water
exercise swimming
program (WESP)
on the aquatic
skills and social
behaviors of 16
boys with autism
spectrum disorders
(ASD)

- Quantitative,
experimental design

- Within-participant
repeated measures
design

- Controlled, singleblind design
- Each participant
was assessed 3
times, once at study
entry (baseline),
second time after 10
weeks of regular
treatment/activity,
third time after
another 10 weeks

Limitations
- Low same size,
small age range, and
single gender of
participants (male)
- Difference in
cognitive abilities
and gross motor
skills were not
evaluated and might
have influenced
findings

- Analysis revealed a
significant main
effect of time on the
academic behavior
and all antisocial
behaviors
- Results indicated
that the WESP
improved the aquatic
skills in 4/5 stages as
measured with
percentage scores,
and decreased the

BENEFITS OF NONPHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENTS IN AUTISTIC CHILDREN
Author (Year)
Title
Citation
Swimming
Program on
Aquatic Skills
and Social
Behaviors in
Children with
Autism Spectrum
Disorders.
Autism: The
International
Journal of
Research and
Practice, 14(1),
9–28. Retrieved
from
https://search.ebs
cohost.com/login.
aspx?direct=true
&db=eric&AN=E
J872183&site=ed
s-live

Purpose

Design and Sample

Methods

34

Limitations and
Strengths

Findings

- More research
needed to understand
the impact of these
variables on healthpromoting physical
activities in this
population

total antisocial
behavior problems in
children with ASD

Strengths
- WESP starts with a
mental adjustment to
the activity and
factors associated
with it. As the
program progressed,
more dynamic and
challenging tasks
- Aquatic activity
exercises the total
body without putting
excessive stress or
tension on specific
body parts
- Instructors and
children perform the
same techniques, and
this provides

- All strategies
implemented with
the goal of making
the social interaction
mutually reinforcing
to both the children
with ASDs and their
instructors and peers
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Title
Citation

Purpose

Design and Sample

Methods

Limitations and
Strengths

35

Findings

opportunities for
children and parents
to participate
together following
identical routines
Effectiveness of
Sensory
Integration
Interventions in
Children with
Autism Spectrum
Disorders: A Pilot
Study
Pfeiffer, B. A.,
Koenig, K.,
Kinnealey, M.,
Sheppard, M., &
Henderson, L.
(2011).
Effectiveness of
sensory
integration
interventions in
children with
autism spectrum
disorders: a pilot
study. American

To provide
preliminary
information on the
effectiveness of SI
interventions for
children with
ASDs and to
obtain pilot data to
guide future

- Pilot study

- Children ages 6-12
with ASD who
attended a summer
therapeutic
activities program,
were randomly
assigned to a fine
motor or SI
treatment group

Limitations
- Issues with
objective
measurement tools
for children on the
autistic spectrum
(standardized
measures are
inappropriate
because of the wide
- Total of 32 boys
variety in behavioral
and 5 girls, similar
and developmental
to ratio of ASD
levels and the ability
of a child with ASD
- Interventions were to complete the test
provided in context while maintaining
of the summer
test validity
therapeutic
activities program
- Ensure participants
are more
homogenous so
effectiveness of
interventions can be

- Results identified
significant positive
changes in Goal
Attainment SCaling
scores for both
groups, more
significant changes
occurred in the SI
group, and a
significant decrease
in autistic
mannerisms occurred
in the SI group
- Results showed
significant post
intervention
differences in social
responsiveness
between the SI and
FM group
- Children in the SI
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Author (Year)
Title
Citation
Journal of
Occupational
Therapy, 65(1),
76–85.
https://doi.org/10.
5014/ajot.2011.09
205

Purpose

Design and Sample

Methods

Limitations and
Strengths
detected, the group in
this study varied
greatly in their
adaptive behavioral
levels
- Carry over
interventions
throughout daily
routines which is
more characteristic
of OT services, and
use measurement
tools that are more
individualized due to
the diverse nature of
people with autism
- This study was over
a short period of
time, 3x/week for 6
weeks
Strengths
- Multiple
procedures/measure
ment tools used to
identify and narrow
results

Findings

group had
significantly fewer
autistic mannerisms
after interventions

36
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Title
Citation

Purpose

Design and Sample

Methods

Limitations and
Strengths

Findings

- Treatment
interventions were
based on the
individual needs of
each child but
included the 10 key
therapeutic strategies
identified in the
fidelity tool
- Results of study
were mixed yet
demonstrated
significant changes
in the autistic
mannerisms
(component of social
responsiveness) and
significant progress
toward individual
goals in the areas of
sensory processing
and regulation,
social-emotional
function, and FM
skills
Psychotropic

To examine

- Quantitative

- IAN project data:

Limitations

- A total of

37
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Title
Citation

Purpose

Medication Use
Among Children
With Autism
Spectrum
Disorders
Enrolled in a
National Registry,
2007-2008

patterns of current
psychotropic
medication use
among 5,181
children with
autism spectrum
disorders (ASD)
enrolled in a Webbased registry

Rosenberg RE,
Mandell DS,
Farmer JE, Law
JK, Marvin AR,
& Law PA.
(2010).
Psychotropic
medication use
among children
with autism
spectrum
disorders enrolled
in a National
Registry, 20072008. Journal of
Autism &
Developmental
Disorders, 40(3),
342–351.

1. Confirm
Mandell’s findings
regarding factors
influence
psychotropic
medication use and
comparative
prevalence in a
unique national
dataset, the
Interactive Autism
Network (IAN)
which includes
children of varying
insurance status
2. Test the
hypothesis that
insurance status—

Design and Sample

- IAN: Internet
based research
database

Methods

All families
complete an initial
registration and
then are invited to
complete several
other
questionnaires,
including a profile
on each affected
child and a list of
treatments that the
child currently
receives
- Families do not
supply overall
insurance status in
the IAN survey.
Therefore, to
examine the effects
of type of insurance
on psychotropic
medication use, we
examined data from
all subjects who
reported use of at
least one
medication and who
reported payer

38

Limitations and
Strengths

Findings

- The data are
provided by Webbased parent-report,
so diagnosis and
treatment use are not
validated

5,181 children in our
sample had complete
child and treatment
information from
April 2007 through
October 20, 2008.
The sample was
predominantly 6–11
years of age (49%),
was mostly male
(83%), and often
reported psychiatric
comorbidities (39%
with ≥
1 comorbidity)

- Selection bias,
common to other
community- and
clinic-based studies,
toward families with
higher
socioeconomic status
(SES) and with
Internet access
- The insurance data
were linked to
individual treatments
rather than
individuals, and did
not specify the
reason for Medicaid
eligibility (disability,
income, or both)
- The data include
information only on

- Overall, 35.3% of
subjects used at least
one psychotropic
medication at the
time of survey
completion
- The most common
psychotropic
medications were
stimulants,
neuroleptics, and
antidepressants
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Title
Citation

Purpose

https://doi.org/10. in addition to the
1007/s10803-009- demographic
0878-1
variables
previously
associated with
medication use—
affects use of
prescription
medications in
ASD
3. Investigate
prescribing trends
by medical
specialty for
children with ASD,
given limited if
any research in this
area

Design and Sample

Methods

information about
that medication

Limitations and
Strengths
the history of (not
current status)
seizure disorder, we
are not able to
determine if
anticonvulsants are
being prescribed for
mood-stabilizing or
antiepileptic
properties
Strengths
- Compared and
strengthened
previous studies
about psychotropic
med use and in this
study, addressed
demographics and
insurance status

39

Findings

- White and African
American
participants reported
similar percentages
of psychotropic
medication use
- Hispanic
participants were less
likely to use any
psychotropic
medication
- Among those
children using a
psychotropic
medication with
analyzable data (n =
1,575), those with no
reported insurance
coverage were
significantly less
likely to be on more
than two medications
than were those with
private insurance,
Medicaid, or a
combination of
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Author (Year)
Title
Citation

Purpose

Design and Sample

Methods

Limitations and
Strengths

40

Findings

insurance types
Psychotropic
Medication Use
and
Polypharmacy in
Children With
Autism Spectrum
Disorders

To examine rates
and predictors of
psychotropic use
and multiclass
polypharmacy
among
commercially
insured children
with autism
spectrum disorders
Spencer, D.,
Marshall, J., Post, (ASD)
B., Kulakodlu,
M., Newschaffer,
C., Dennen, T.,
Azocar, F., Jain,
A. (2013, October
21). Psychotropic
Medication Use
and
Polypharmacy in
Children With
Autism Spectrum
Disorders.
Pediatrics.

- Retrospective
observational study
using an
administrative
claims database
associated with a
large US
commercial health
plan

- Using medical and
pharmacy claims
data with linked
enrollment
information, a total
of 33 565 children
with ASD who had
at least 6 months of
continuous medical,
pharmacy, and
behavioral health
care coverage
between January
2001 and December
2009 were
identified
- Eligible subjects
had to be between
the age of 0 and 20
years as of their
first day of health
plan enrollment
during the study and
without claims for
childhood

Limitations
- Misclassification of
subjects with and
without ASD is
possible

- More white
children children
ages 11 and older,
had evidence of both
psychotropic use and
polypharmacy

- Administrative
claims data can be
used to document
prescription fills but
not whether the
patient actually took
the prescribed
medication or as
directed, and claims
do not capture overthe counter
medications

- A large proportion
of children with
evidence of epilepsy/
seizures, ADD,
anxiety, depression,
and/or bipolar
disorder were
psychotropic users,
and one-half or more
had evidence of
polypharmacy

- Did not examine
dose or
appropriateness of
dose for a particular
child or a particular
diagnosis because
appropriate dosing

- Among a sample of
33,565 commercially
insured children with
ASD in the United
States, we found that
64% used at least 1
psychotropic
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Author (Year)
Title
Citation
https://doi.org/10.
1542/peds.20123774

Purpose

Design and Sample

Methods

disintegrative
disorder or Rett
syndrome
- Subjects were
required to have 1
period of at least 6
months of
continuous
enrollment but may
have had more
enrollment time
with all 3 types of
coverage during the
study

41

Limitations and
Strengths

Findings

often depends on a
child’s weight
(possibly resulted in
overestimation of
psychotropic use and
polypharmacy)

medication, and just
more than one-third
had evidence of
psychotropic
polypharmacy during
an average length of
enrollment of 3+
years

Strengths
- Detailing
psychotropic use and
polypharmacy
among children with
ASD is crucial for
informing families,
clinicians, and
researchers

- Children from the
southern region were
significantly more
likely than children
from the northeast
and west to be
multiclass
polypharmacy users,
raising questions
about the availability
of
nonpharmacologic,
behaviorally based
services and
treatments in the
south, where other
health outcomes and
health care services
have been found to
be poorer than in
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other parts of the
country
- Study highlights the
need for primary care
providers to carefully
elicit medication
histories and monitor
symptoms for
evidence of
effectiveness
Immediate Effect
of Ayres’s
Sensory
Integration-Based
Occupational
Therapy
Intervention on
Children With
Autism Spectrum
Disorders
Watling RL, &
Dietz J. (2007).
Immediate effect
of Ayres’s
sensory

To examine the
effects of Ayres’s
sensory integration
intervention on the
behavior and task
engagement of
young children
with autism
spectrum disorders
(ASD)

- Single-subject
study used ABAB
design to compare
immediate effect of
Ayres’s sensory
integration and a
play scenario on the
undesired behavior
and task
engagement of 4
children with ASD

- 4 boys between
age 3 years 0
months - 4 years 4
months
- Independently
diagnosed with
ASD
- No comorbid
diagnoses, absence
of seizures, no
concurrent OT
services, no
intention to
add/change meds or
therapy during
course of study

Limitations
- Constraints
imposed by the
operational definition
of engagement
- Small sample size
- Complications in
rating engagement
- Short duration of
the A2 pashes
- Potential bias in
subjective
observations

- Data suggested that
Ayres’s sensory
integration had a
positive effect on
transitions,
socialization,
compliance, and
general behavior
regulation, evident
during intervention
sessions and at in
home environments
- Subjective data
recorded in the study
logs suggest that new
behaviors emerged
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Author (Year)
Title
Citation
integration-based
occupational
therapy
intervention on
children with
autism spectrum
disorders.
American Journal
of Occupational
Therapy, 61(5),
574–583.
Retrieved from
https://search.ebs
cohost.com/login.
aspx?direct=true
&db=ccm&AN=1
05971173&site=e
ds-live

Purpose

Design and Sample

Methods

Limitations and
Strengths
recorded by study
personnel and
caregivers
Strengths
- Study was carried
out in a systematic
manner and
treatment sessions
met proposed criteria
for Ayres’s sensory
integration
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during the Ayres’s
sensory integration
sessions for each
participant;
behaviors changed in
home environments
as well

- Results of this
study were consistent
with those reported
by Smith et al.
(2005), who found
no change in
- Both interventions
frequency of
were carried out by
undesired behaviors
same OT, controlling immediately after
effect of therapist
Ayres’s sensory
characteristics on
integration
therapist-participant
interaction
- Raters for
engagement and
undesired behavior
were blind to which
intervention
condition preceded
the data collection
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period
- Study had high
interrater agreement
on the dependent
variable ratings and
high procedural
reliability
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